Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1988 2
1990 3
1991 4
1992 1
1993 3
1994 4
1995 3
1996 1
1997 1
1998 4
1999 4
2000 4
2001 4
2002 5
2003 2
2004 3
2005 1
2006 1
2007 4
2008 10
2009 9
2010 1
2011 1
2012 1
2013 1
2014 1
2017 1
2018 1
2019 1
2021 1
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Results by year

Filters applied: . Clear all
Page 1
ALK5 inhibition in renal disease.
Laping NJ. Laping NJ. Curr Opin Pharmacol. 2003 Apr;3(2):204-8. doi: 10.1016/s1471-4892(03)00002-x. Curr Opin Pharmacol. 2003. PMID: 12681245 Review.
TGF-beta 1 is an organizer of responses to neurodegeneration.
Finch CE, Laping NJ, Morgan TE, Nichols NR, Pasinetti GM. Finch CE, et al. Among authors: laping nj. J Cell Biochem. 1993 Dec;53(4):314-22. doi: 10.1002/jcb.240530408. J Cell Biochem. 1993. PMID: 8300749 Review.
TLR2 agonism reverses chemotherapy-induced neutropenia in Macaca fascicularis.
Laping NJ, DeMartino MP, Cottom JE, Axten JM, Emery JG, Guss JH, Burman M, Foley JJ, Cheung M, Oliff A, Kumar S. Laping NJ, et al. Blood Adv. 2017 Dec 8;1(26):2553-2562. doi: 10.1182/bloodadvances.2017010611. eCollection 2017 Dec 12. Blood Adv. 2017. PMID: 29296907 Free PMC article.
Broad Kinase Inhibition Mitigates Early Neuronal Dysfunction in Tauopathy.
Koren SA, Hamm MJ, Cloyd R, Fontaine SN, Chishti E, Lanzillotta C, Rodriguez-Rivera J, Ingram A, Bell M, Galvis-Escobar SM, Zulia N, Di Domenico F, Duong D, Seyfried NT, Powell D, Vandsburger M, Frolinger T, Hartz AMS, Koren J 3rd, Axten JM, Laping NJ, Abisambra JF. Koren SA, et al. Among authors: laping nj. Int J Mol Sci. 2021 Jan 26;22(3):1186. doi: 10.3390/ijms22031186. Int J Mol Sci. 2021. PMID: 33530349 Free PMC article.
Sustained elevation of MG53 in the bloodstream increases tissue regenerative capacity without compromising metabolic function.
Bian Z, Wang Q, Zhou X, Tan T, Park KH, Kramer HF, McDougal A, Laping NJ, Kumar S, Adesanya TMA, Sermersheim M, Yi F, Wang X, Wu J, Gumpper K, Jiang Q, He D, Lin PH, Li H, Guan F, Zhou J, Kohr MJ, Zeng C, Zhu H, Ma J. Bian Z, et al. Among authors: laping nj. Nat Commun. 2019 Oct 11;10(1):4659. doi: 10.1038/s41467-019-12483-0. Nat Commun. 2019. PMID: 31604915 Free PMC article.
Improving the developability profile of pyrrolidine progesterone receptor partial agonists.
Kallander LS, Washburn DG, Hoang TH, Frazee JS, Stoy P, Johnson L, Lu Q, Hammond M, Barton LS, Patterson JR, Azzarano LM, Nagilla R, Madauss KP, Williams SP, Stewart EL, Duraiswami C, Grygielko ET, Xu X, Laping NJ, Bray JD, Thompson SK. Kallander LS, et al. Among authors: laping nj. Bioorg Med Chem Lett. 2010 Jan 1;20(1):371-4. doi: 10.1016/j.bmcl.2009.10.092. Epub 2009 Oct 25. Bioorg Med Chem Lett. 2010. PMID: 19926282
Rational design of orally-active, pyrrolidine-based progesterone receptor partial agonists.
Thompson SK, Washburn DG, Frazee JS, Madauss KP, Hoang TH, Lapinski L, Grygielko ET, Glace LE, Trizna W, Williams SP, Duraiswami C, Bray JD, Laping NJ. Thompson SK, et al. Among authors: laping nj. Bioorg Med Chem Lett. 2009 Aug 15;19(16):4777-80. doi: 10.1016/j.bmcl.2009.06.055. Epub 2009 Jun 17. Bioorg Med Chem Lett. 2009. PMID: 19595590
80 results